SCHEMBL19377411

SCHEMBL19377411

CCOc1ccc(Cl)c(C(=O)NC(=O)Nc2ccc(S(=O)(=O)Nc3ccc4c(c3)CNC4)cc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PCTP Q9UKL6 5/20 0.47
▸ DRD2 P14416 1/20 0.47
▸ DRD3 P35462 1/20 0.47
▸ HTR6 P50406 1/20 0.47
▸ TAS1R3 Q7RTX0 1/20 0.46
▸ TAS1R1 Q7RTX1 1/20 0.46
▸ KMT2A Q03164 3/20 0.45
▸ GHSR Q92847 1/20 0.45
▸ STARD10 Q9Y365 2/20 0.45
▸ STARD7 Q9NQZ5 1/20 0.45
▸ ALDH1A1 P00352 4/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ OGG1 O15527 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ GAA P10253 2/20 0.43
▸ NPSR1 Q6W5P4 3/20 0.42
▸ MAPT P10636 3/20 0.42
▸ LMNA P02545 2/20 0.42
▸ ALOX12 P18054 2/20 0.42
▸ POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19377110 0.87 DRD2 (0.54) PCTPDRD2DRD3HTR6KMT2A
SCHEMBL19377430 0.87 GHSR (0.46) PCTPTAS1R3TAS1R1KMT2AGHSR
SCHEMBL19377302 0.81 HTR6 (0.57) PCTPDRD2DRD3HTR6KMT2A
SCHEMBL19377147 0.79 POLB (0.52) PCTPKMT2AGHSRALDH1A1MEN1
SCHEMBL19377387 0.75 GHSR (0.45) PCTPDRD2DRD3HTR6KMT2A
SCHEMBL13454712 0.69 ALDH1A1 (0.69) PCTPKMT2AALDH1A1MEN1GAA
SCHEMBL13454737 0.68 PCTP (0.69) PCTPTAS1R3TAS1R1KMT2ASTARD10
SCHEMBL19377401 0.67 GHSR (0.70) PCTPGHSR
SCHEMBL19377297 0.67 GHSR (0.47) KMT2AGHSRALDH1A1MEN1GAA
SCHEMBL19377360 0.67 HSD17B10 (0.52) DRD2DRD3HTR6KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US claimed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
WO-2017162390-A1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2017-09-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof UTS2R, GHSR, GRPR PCTP 2942/4885DRD2 4443/4885DRD3 4367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback